QA: Rezolute Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2020_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 12,144,000
1 IntangibleAssetsNetIncludingGoodwill 29,000
2 PropertyPlantAndEquipmentNet 44,000
3 remainder_Assets 35,000
4 LiabilitiesCurrent 8,379,000
5 LiabilitiesNoncurrent 527,000
6 remainder_Liabilities 1,594,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,643,976
9 ResearchAndDevelopmentExpense 23,069,461
10 remainder_Expenses 856,293
11 remainder_Revenues 0
12 remainder_NetIncome -3,961,172
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,252,000
1 Liabilities 10,500,000
2 Expenses 30,569,730
3 Revenues 0
4 StockholdersEquity 1,752,000
5 NetIncome -34,530,902
6 ComprehensiveNetIncome -34,530,902
7 BaseVar 28,641,451
8 EconomicCapitalRatiobeforeLimitedLiability -2.70
9 EconomicCapitalRatio 0.787

Edgar->Model Mapping

Feature Distribution

Change over Time